Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biontech Se ADR
(NQ:
BNTX
)
87.25
+2.40 (+2.83%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
750,402
Open
84.34
Bid (Size)
86.44 (1)
Ask (Size)
87.26 (4)
Prev. Close
84.85
Today's Range
84.34 - 87.57
52wk Range
76.53 - 125.83
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Struggling COVID-19 Vaccines From AstraZeneca, BioNTech/Pfizer, Moderna Cut Incidence Of Arterial Thromboses That Cause Heart Attacks, Strokes, British Study Shows
August 13, 2024
COVID-19 vaccinations could lower the incidence of heart attacks and strokes, according to a new study by UK universities. The research shows a significant reduction in cardiovascular events among...
Via
Benzinga
Exposures
COVID-19
Long Covid Remains Diagnostic Mystery, Diagnosis Remains Elusive; National Institutes of Health-Funded Study Shows
August 13, 2024
A recent NIH study reveals no clear diagnostic test for Long Covid, highlighting ongoing challenges in identifying and treating the condition affecting millions of Americans. Researchers continue to...
Via
Benzinga
Exposures
COVID-19
Performance
YTD
-22.34%
-22.34%
1 Month
+3.56%
+3.56%
3 Month
-5.37%
-5.37%
6 Month
-4.60%
-4.60%
1 Year
-17.46%
-17.46%
More News
Read More
Novavax Plunges on Earnings Miss: Falling Knife or Buying Opp?
August 12, 2024
Via
MarketBeat
Exposures
COVID-19
3 Biotech Stocks With Promising Drug Pipelines: August 2024
August 08, 2024
Via
InvestorPlace
Exposures
Product Safety
Navigating 12 Analyst Ratings For BioNTech
August 01, 2024
Via
Benzinga
This Cognizant Technology Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday
August 07, 2024
Via
Benzinga
BioNTech Se (BNTX) Q2 2024 Earnings Call Transcript
August 05, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
US Stocks Trim Black Monday's Drops As Services Gauge Expands, Bond Gains Stall As Traders Reassess Fed Cuts: What's Driving Markets Monday?
August 05, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Moderna Lost 27% Of Its Value Over Two Days. It Just Crumbled Again.
August 05, 2024
Via
Investor's Business Daily
BNTX Stock Earnings: BioNTech Misses EPS, Misses Revenue for Q2 2024
August 05, 2024
Via
InvestorPlace
BioNTech's Q2 Loss Widens Amid Low Demand For Its Pfizer-Partnered COVID-19 Vaccine, Increases R&D Spending On New Cancer Products
August 05, 2024
Via
Benzinga
Exposures
COVID-19
Nasdaq, R2K Futures Tumble Over 4%, VIX Spikes Over 100%, Bitcoin Plunges Hard As Global Sell-Off Deepens Amid Recession Fears
August 05, 2024
Via
Benzinga
Topics
Economy
Stocks
Exposures
Economy
US Equities
BioNTech Announces Second Quarter 2024 Financial Results and Corporate Update
August 05, 2024
From
BioNTech SE
Via
GlobeNewswire
What's Going On With BioNTech (BNTX) Shares?
August 01, 2024
Via
Benzinga
Moderna Slashes Its Outlook On 'Very Low' European Sales Despite Quarterly Beat
August 01, 2024
Via
Investor's Business Daily
BioNTech Announces Positive Topline Phase 2 Results for mRNA Immunotherapy Candidate BNT111 in Patients with Advanced Melanoma
July 30, 2024
From
BioNTech SE
Via
GlobeNewswire
Week In Review: Nanjing Triastek Partners With BioNTech In A $1.2 Billion Drug Development Deal
July 27, 2024
Via
Talk Markets
BioNTech to Report Second Quarter 2024 Financial Results and Corporate Update on August 5, 2024
July 22, 2024
From
BioNTech SE
Via
GlobeNewswire
European Commission Faces Court Criticism Over COVID Vaccine Contract Transparency Ahead Of Vote on Ursula Von Der Leyen's Reappointment
July 17, 2024
Via
Benzinga
Exposures
COVID-19
GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B
July 03, 2024
Via
Benzinga
Exposures
COVID-19
London High Court Ruling Fuels Pfizer And Moderna Legal Dispute Over COVID-19 Vaccine Patents
July 02, 2024
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
July 02, 2024
Via
MarketBeat
Topics
ETFs
Exposures
COVID-19
3 Nasdaq Stocks to Sell in July Before They Crash & Burn
July 02, 2024
Via
InvestorPlace
Surprise! 3 Stocks That Are Outperforming Nvidia in 2024.
July 01, 2024
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
3 Dividend Stocks Yielding Over 3% With Multi-Decade Payout Growth Streaks
July 01, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.